{
  "guideline": {
    "id": "PA166123487",
    "name": "Annotation of FDA Label for eliglustat and CYP2D6",
    "objCls": "Label Annotation",
    "source": "FDA",
    "version": 32,
    "url": "https://www.pharmgkb.org/labelAnnotation/PA166123487",
    "relatedChemicals": [
      {
        "id": "PA166123486",
        "name": "eliglustat",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA128",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "symbol": "CYP2D6"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166309019",
      "name": "Recommendation Annotation PA166309019",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198038,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥5.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309006",
      "name": "Recommendation Annotation PA166309006",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198025,
        "html": "<p>CYP2D6 normal metabolizers have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "1.5"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309008",
      "name": "Recommendation Annotation PA166309008",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198027,
        "html": "<p>CYP2D6 normal metabolizers have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.0"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309010",
      "name": "Recommendation Annotation PA166309010",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198029,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309001",
      "name": "Recommendation Annotation PA166309001",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198020,
        "html": "<p>CYP2D6 IMs have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "0.25"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309012",
      "name": "Recommendation Annotation PA166309012",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198031,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309003",
      "name": "Recommendation Annotation PA166309003",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198022,
        "html": "<p>CYP2D6 IMs have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "0.75"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309014",
      "name": "Recommendation Annotation PA166309014",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198033,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309005",
      "name": "Recommendation Annotation PA166309005",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198024,
        "html": "<p>CYP2D6 normal metabolizers have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "1.25"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309016",
      "name": "Recommendation Annotation PA166309016",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198035,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309007",
      "name": "Recommendation Annotation PA166309007",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198026,
        "html": "<p>CYP2D6 normal metabolizers have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "1.75"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309018",
      "name": "Recommendation Annotation PA166309018",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198037,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309009",
      "name": "Recommendation Annotation PA166309009",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198028,
        "html": "<p>CYP2D6 normal metabolizers have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.25"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309020",
      "name": "Recommendation Annotation PA166309020",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198039,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥6.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309011",
      "name": "Recommendation Annotation PA166309011",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198030,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309013",
      "name": "Recommendation Annotation PA166309013",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198032,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166307941",
      "name": "Recommendation Annotation PA166307941",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452189360,
        "html": "<p>CYP2D6 poor metabolizers have a recommended dose of 84 mg once daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "0.0"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309015",
      "name": "Recommendation Annotation PA166309015",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198034,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309002",
      "name": "Recommendation Annotation PA166309002",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198021,
        "html": "<p>CYP2D6 IMs have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "0.5"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166309017",
      "name": "Recommendation Annotation PA166309017",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198036,
        "html": "<p>&quot;CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA [eliglustat] to achieve a therapeutic effect.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166309004",
      "name": "Recommendation Annotation PA166309004",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166123486",
          "name": "eliglustat",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198023,
        "html": "<p>CYP2D6 IMs have a recommended dose of 84 mg orally twice daily.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "1.0"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": null,
      "title": "Drugs@FDA: Drug Product Cerdelga (eliglustat), NDA205494, Genzyme Corporation",
      "authors": [],
      "journal": null,
      "year": -1,
      "_sameAs": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205494"
    }
  ],
  "version": "2024-03-08-14-34"
}